Rhenman & Partners Asset Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-5,179
| Closed | -$441K | – | 97 |
|
|
2017
Q2 | $441K | Hold |
5,179
| – | – | 0.06% | 90 |
|
|
2017
Q1 | $497K | Buy |
5,179
+3,512
| +211% | +$337K | 0.08% | 86 |
|
|
2016
Q4 | $361K | Hold |
1,667
| – | – | 0.07% | 90 |
|
|
2016
Q3 | $616K | Sell |
1,667
-4,085
| -71% | -$1.51M | 0.1% | 91 |
|
|
2016
Q2 | $1.28M | Hold |
5,752
| – | – | 0.23% | 86 |
|
|
2016
Q1 | $1.74M | Buy |
5,752
+648
| +13% | +$196K | 0.35% | 79 |
|
|
2015
Q4 | $2.43M | Buy |
5,104
+97
| +2% | +$46.1K | 0.37% | 80 |
|
|
2015
Q3 | $2.43M | Buy |
5,007
+583
| +13% | +$283K | 0.39% | 69 |
|
|
2015
Q2 | $3.24M | Buy |
+4,424
| New | +$3.24M | 0.39% | 76 |
|